FDA clears Medtronic's Euphora balloon

The FDA grants 510(k) clearance to Medtronic for its Euphora semicompliant balloon dilation catheter for coronary stenting procedures.

Medtronic (NYSE:MDT) today said the FDA cleared its Euphora semicompliant balloon dilation catheter, and the company wasted no time in getting the pre-stenting device on the U.S. market.

Food & Drug Administration (FDA), Medtronic

News Well, 510(k), Catheters, Regulatory/Compliance, Stents

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zKauc1